Schedule 13G ownership disclosure
GT Biopharma, Inc.
Security class unavailable · CUSIP: 36254L100
Event date: 2019-01-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 8.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000939798-19-000004
- Form type
- SC 13G
- Filer
- GT Biopharma, Inc.
- CIK
- CIK 109657
- Filed
- Feb 05, 2019
- Reporting period
- Jan 22, 2019
- Description
- Schedule 13G beneficial ownership